
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
Chaccour, Carlos, Ruiz-Castillo, Paula, Richardson, Mary-Ann, Moncunill, Gemma, Casellas, Aina, Carmona-Torre, Francisco, Giráldez, Miriam, Mota, Juana Schwartz, Yuste, José Ramón, Azanza, José RaVolume:
21
Journal:
Trials
DOI:
10.1186/s13063-020-04421-z
Date:
December, 2020
Fichier:
PDF, 445 KB
2020